Showing posts with label Biotechnology. Show all posts
Showing posts with label Biotechnology. Show all posts
Friday, 21 October 2022

IPOs in the United States Drop

›
According to Ernst & Young and PwC , the number of IPOs and their value in the United States have dropped significantly from the simila...
Saturday, 20 November 2021

The U.S. Funding of the Moderna mRNA Technology and a Patent Dispute

›
Ana Santos Rutschman at Saint Louis University Law School has authored an interesting short article titled, "Why Moderna Won't Sha...
Tuesday, 3 August 2021

Who Benefits from the Fruit of Research from Human Cells? Civil Rights Attorney Representing Henrietta Lacks Family

›
In a fascinating turn of events, Ben Crump , the prominent civil rights attorney who represented the family of Treyvon Martin and Breonna Ta...
Sunday, 9 May 2021

It is simplistic and short-sighted to undermine Covid-19 patent rights

›
President Biden’s administration is making a major mistake by its top trade advisor, Katherine Tai, advocating a waiver of patent rights for...
Friday, 6 March 2020

Alliance for Regenerative Medicine: 2019 is Second Best Year in History for Regenerative Medicine Financing

›
The Alliance for Regenerative Medicine (ARM) has recently released its annual report .  Notably, ARM states that 2019 was the second-best...
Friday, 18 October 2019

Improving the Allocation of Resources: Artificial Intelligence to Predict Future Clinical Success of Basic Research

›
In a new paper published on October 10, 2019 titled, “Predicting Translational Progress in Biomedical Research,” authors B. Ian Hutchins,...
Thursday, 18 July 2019

New Report: UK's Cell and Gene Therapy Sector Growing at a (very) Healthy Rate

›
The Alliance for Regenerative Medicine and the Bioindustry Association of the UK have released a report (Report) concerning development a...
Thursday, 21 February 2019

Heavily Taxing Billionaires to Promote Innovation

›
An important issue confronting the world concerns the high concentration of wealth and redistribution of that wealth through the tax syste...
Wednesday, 30 May 2018

FDA Attempts to Shame Pharmacuetical and Biotechnology Companies

›
The U.S. Federal Drug Administration (FDA) recently decided to try to “shame” some pharmaceutical and biotechnology companies for failin...
Tuesday, 10 April 2018

Chinese National Convicted of Conspiracy to Steal Trade Secrets in Kansas

›
Recently, Newsweek has published an article titled, “A Chinese Scientist Stole American Rice and will Spend a Decade in Prison,” by Max ...
Thursday, 8 March 2018

EPO Releases Annual Report on 2017 Patent Activity: Interesting Stats

›
The EPO has released its annual report for 2017 patenting activity.   Notably, patenting and patent filings are trending up at 3.9% and ...
Tuesday, 6 June 2017

Biotechnology Stock Value: Uncertainty the New Normal or Just the Same Old Deal?

›
In a recent article in the Wall Street Journal, What's Behind the Biotech Sector's Rebound: Biotech ETFs are Getting Hearts Pumping...
Thursday, 26 January 2017

The Big Boys and Smaller Players of Technology Transfer Offices

›
One criticism of technology transfer offices is that some may have difficulty making enough money through deals to cover their overhead.  ...
Wednesday, 29 April 2015

Biotechnology Stock Value Swings

›
In a July 6, 2013 post , this blog discussed the upswing in biotechnology patenting and the rising numbers of biotechnology IPOs.   The blog...
Tuesday, 25 March 2014

Patent Trolls Coming Soon to the Bio-pharmaceutical Industry--and a Roadmap?

›
In a recent article titled “ Patent Trolling: Why Bio and Pharmaceuticals Are at Risk ”, Professor Robin Feldman of University of Californi...
Saturday, 5 January 2013

OECD 2012 Updated Biotechnology Indicators: Funding for IP and Other Interesting Stats

›
The OECD recently released its updated 2012 Biotechnology Indicators here . Some of the statistics are updated and others are not. On the nu...
2 comments:
Wednesday, 4 November 2009

Open Source and Biotechnology: Whither or Whether Ideology?

›
I venture to say that most of us are well aware of the fault lines between proprietary and open source software. Proprietary software is cha...
4 comments: